Shankar Siva路 @_ShankarSiva 路 X路路 1 day agoScore70
Body
#ESMO26 @tompowles1 presents at the 馃憫presidential 馃憫 session VOLGA n=1009 phIII neoadjuvant #bladdercancer trial. 24mo EFS 63.5% vs 45% (HR 0.51), pCR 45% vs 10%. Triplet +tremelimumab hits EFS but not yet OS. #MIBC - @NEJM paper 鉃★笍 鉃★笍 https://shorturl.at/7cyc9
146 views 路 2 likes 路 2 reposts 路 0 replies
Conference abstracts
LBA2matched by Presidential Symposium I
Perioperative durvalumab with or without tremelimumab plus neoadjuvant enfortumab vedotin in muscle-invasive bladder cancer: Results from the phase 3 VOLGA trial
https://esmocongress.esmo.orgVOLGA
https://esmocongress.esmo.orgSource: Shankar Siva 路 x.com